Clinical Trial Update: Short-course Radiotherapy in TNT Combined With Enlonstobart for pMMR LARC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating short-course radiotherapy in total neoadjuvant therapy combined with Enlonstobart for pMMR locally advanced rectal cancer; recruitment …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Enlonstobart

Snippet

Sponsor: Hebei Medical University Fourth Hospital | Conditions: Efficacy and Safety of Short-course Radiotherapy in Total Neoadjuvant Therapy Combined With Enlonstobart for pMMR Locally Advanced Rectal Cancer | Phase 2 | Status: NOT_YET_RECRUITING